| View printer-friendly version |
| << Back |
Aerpio Therapeutics Announces Publication of Positive Results of Phase 1b/2a Clinical Trial of Novel Tie2 Activator, AKB-9778, for the Treatment of Patients with Diabetic Macular Edema (DME) - TIME-1 Study
Positive-Results-Phase-1b-2a.pdf 561.3 KB